Healthcare -
Biotechnology - NASDAQ - US
$ 3.345
1.36 %
$ 634 M
Market Cap
-7.78
P/E
ABUS - SHORT-TERM DEBT
Short-term Debt ABUS - Arbutus Biopharma Corporation
425 K
LAST VALUE
-25.51%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR